Dabigatran reduces major CV complications in patients with myocardial injury after noncardiac surgery
Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart attack, stroke and other heart or blood-vessel complications among patients who were at elevated risk for these events because ...
Mar 12, 2018